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The clearest example of genomlc Imprinting In humans comes from studies of the Angelman (AS) and Prader-Wllll
(PWS) syndromes. Although these are clinically distinct disorders, both typically result from a loss of the same
chromosomal region, 15q11 -q13. AS usually results from either a maternal deletion of this region, or paternal
unlparental dlsomy (UPD; both chromosomes 15 Inherited from the father). PWS results from paternal deletion
of 15q11 - q13 or maternal UPD of chromosome 15. We have recently described a parent-specific DNA methylation
imprint in a gene at the D15S9 locus (new gene symbol, ZNF127), within the 15q11 -q13 region, that identifies
AS and PWS patients with either a deletion or UPD. Here we describe an AS slbshlp and three PWS patients
In which chromosome 15 rearrangements alter the methylation state at ZNF127, even though this locus Is not
directly Involved in the rearrangement. Parent-specific DNA methylation Imprints are also altered at ZNF127 and
D1SS63 (another locus with a parent-specific methylation Imprint) In an AS slbshlp which have no detectable
deletion or UPD of chromosome 15. These unique patients may provide Insight Into the Imprinting process that
occurs In proximal chromosome 15 in humans.
INTRODUCTION
Genomic imprinting refers to the epigcnetic modification of
nuclear DNA which results in the differential expression of
maternal and paternal alleles during development. Initial evidence
for imprinting came from mouse studies (reviewed in 1), but in
humans the Angelman (AS) and Prader-WiDi (PWS) syndromes
provide a unique model by which to study genomic imprinting.2
Clinical features of AS include severe mental retardation with
absence of speech, ataxia, seizures, inappropriate laughter and
microbrachycephaly.3 Phenotypic features of PWS include
infantile hypotonia, mild to moderate mental retardation,
hyperphagia with subsequent obesity, hypogonadism, short
stature, mild facial dysmorphism, and a characteristic behavior.4
These clinically distinct rieuiobehavioraiydevelopinental disorders
can be distinguished by the parental origin of the lSql 1 — ql3
loss. Lack of a maternal lSql 1 —ql3 contribution results in AS,
most commonly by maternal deletion,516'7-8 or rarely from
paternal UPD.9-10 PWS results from the lack of a paternal
contribution of this same region, either by paternal deletion
n.12,13
 OT by maternal UPD.12-13-14 The extent of the deletion
region is surprisingly homogeneous for the 70—80% of AS and
PWS patients that exhibit a 15qll—ql3 deletion,8-12-13 since
greater than 95% of these patients are hemizygous for the same
set of loci "-16 (see Figure 1).
In AS, there is a significant group of patients (20—25%) that
have biparental inheritance of 15qll-ql3, and they are presently
phenotypically indistinguishible from deletion and UPD
patients.3 These patients may have mutations of an AS gene
within the 15ql l -ql3 region. There are patients that have
atypical PWS which show many or all of the phenotypic features
of PWS, but in a milder form, and have biparental inheritance
of lSqll —ql3.12-13 Since there are most likely few or no
biparental PWS patients with the classical phenotype,12-13 there
may be at least two genes responsible for the full expression of
this syndrome. The atypical PWS patients may result from
mutations or aberrant expression of only one of the two or more
genes responsible for PWS, or alternatively, from unlinked
mutations.
It has been suggested that a DNA methylation imprint is
characteristic of a functional imprint.18-20-21 We have previously
described a parent-specific DNA methylation imprint detected
by the cDNA DN34 within 15qll—ql3 that distinguishes AS
and PWS deletion and UPD DNA samples extracted from
peripheral blood leukocytes.18 The methylation analysis of this
locus, as with all other current techniques, cannot typically
diagnose the biparental AS and atypical PWS patients. Recently,
we have found that this locus (P15S9) encodes a novel zinc finger
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gene, ZNF127 (Jong et al., in preparation). More recently, a
microdissection clone within 15qll - q l 3 , PW71 (D15S63), has
also been demonstrated to detect a parent-specific DNA
methylation imprint.19 Further studies are required to determine
if the ZNF127 gene is functionally imprinted, or if D15S63
encodes a gene that is imprinted.
Here we describe DNA methylation studies of several AS and
PWS patients with unique chromosome 15 rearrangements. We
show that these patients, who maintain biparental inheritance for
ZNF127, nonetheless exhibit an altered DNA methylation imprint
at this locus. Chromosomal rearrangements distant from ZNF127
on chromosome IS may disrupt the topological structure of the
chromosome, thereby affecting the normal methylation state. In
addition, an AS sibship having no detectable rearrangement also
exhibited altered methylation at the ZNF127 and D1SS63 loci,
which may be the result of a mutation in the imprinting process.
RESULTS
DNA methylation of unique AS and PWS patients at the
D15S9 locos
Three siblings with classical features of AS resulting from a small
deletion of 15q l l -q l3 have been described.16-22-23 These
patients are deleted for the D15S10,21 D15S113,16 and GABRB3
loci23 (Fig. 1 and Table 1; AS013P1, P2, P3). The maternal
grandfather has the deletion and passed it on to his phenotypkally
normal daughter. Maternal transmission of this deletion to her
three siblings resulted in AS. Because these siblings have both
a maternal and paternal allele at ZNF127,23 the methylation at
this locus might be expected to have a normal pattern. However,
the DNA methylation pattern at ZNF127 from peripheral blood
leukocytes was found to be altered in the affected siblings in this
family. Figure 2a shows that the phenotypkally normal parents
(lanes 1, 2) have a normal methylation pattern, the two male
siblings (lanes 3, 4) have a reduction of the 4.3, 4.0, and 3.5
kb bands compared to normal controls, but the female sibling
in lane 5 has a methylation pattern similar to the AS UPD sample
in lane 7.
Two AS siblings from another family have biparental
inheritance and exhibit no detectable deletion when probed with
eight probes specific to 15q l l -q l3 (Table 1; AS157P1 and
AS157P2). As seen in Figure 2a, lanes 8 and 9, the methylation
of ZNF127 is like that seen in the AS UPD sample in lane 7.
Because no chromosome 15 alterations have been detected with
probes currently available (Fig. 1; Table 1), we postulate that
these two siblings either have a small deletion within lSql 1 — ql3,
or, more likely, that there is an alteration in the 15qll—ql3.
imprinting process (see Discussion).
Laser densitometry scanning was performed on all patient
samples, as well as a panel of normal controls (Driscoll et al.,
in preparation). Using a ratio of the intensity of the 4.0 + 4.3
kb bands ('maternal' allele) divided by me 3.5 kb band ('paternal'
allele) we are able to distinguish AS ddetkm/UPD (range
0.09-0.69; median 0.37, n = 13) from normal controls (range
0.82-2.35; median 1.67, n = 10) and from PWS deletion/UPD
patient samples (range 4.71-11.66; median 8.22, n = 14).
Figure 2b shows scans of key samples from Figure 2a, in which
the 3.5, 4.0, and 4.3 kb bands are indicated. Note the similar
peak heights of the 4.0 and 4.3 kb bands in the AS samples having
biparental inheritance for ZNF127 in lanes 5 (ratio = 0.65), 8
(ratio = 0.61), and 9 (ratio = 0.38) compared to the AS UPD
in lane 7 (ratio = 0.51). While the AS siblings in lanes 3 and
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Figure 1. Genetic map of loci within proximal human chromosome 15. Probe
or alternative n u n ire in parentheses. The horizontal broken lines indicate the
chromosomal region which ii deleted in over 93% of all AS and PWS patients.
The hatched boxes on the left indicate the regions of chromosome deletion in
the patients of this study. The deletion in the AS013 family is found in the three
affected siblings, their mother, and the maternal grandfather. PW66 and PW108
have ring 15 chromosomes, and the bars at die top and bottom are to indicate
subtdomeric ISp and 15q deletions. Distances between loci are not drawn to
scale. The order as listed is according to D.Ledbetter a al. (personal
4 had a reproducible reduction in their 3.5,4.0, and 4.3 kb bands
their ratios (1.29 and 1.82, respectively) were within the normal
range. Intriguingly, the phenotypically normal mother of the two
AS siblings in lanes 8 and 9 does not have a normal methylation
pattern (lane 10, ratio = 3.87), while the father has a normal
methylation pattern (ratio = 1.82, data not shown). This family
has been analyzed three times, always with similar results.
One classical and two clinically atypical PWS patients having
biparental inheritance of Z/VF727(see Table 1; PW93, PW108,
and PW66) also exhibit altered methylation at this locus. PW93
is a classical PWS patient previously reported to be deleted for
D15S63, D15S10, P, and D15S24, but intact for loci more
proximal to the centromere, including ZNF127.12*4 The
methylation pattern at ZNF127 for PW93 was found to be similar
to that of a maternal UPD (Fig.3a and 3b; lane 4, ratio = 5.85,
and lane 3, ratio = 9.41). Two clinically atypical PWS patients,
PW108 and PW66, shown cytogenetically to have ring 15
chromosomes with subtelomeric deletions of 15p and 15q, were
also found to have an altered methylation at ZNF127(sec Fig. 3),
even though they show biparental inheritance for the entire
15ql l -q l3 region. Molecular analysis of the 15q subtelomeric
VNTR locus D15S86 indicates that in both cases the ring 15
chromosome is of paternal origin. Densitometry ratios of these
patients are 3.46 for PW66 (lane 2) and 4.50 for PW108 (lane
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DNA methylation has been shown to affect the expression of
certain genes,36 and therefore a change in the methylation slate
as described here could have a subsequent effect on transcription
of those genes involved. Recently, StOger et al.21 have
demonstrated a direct correlation between a functional imprint
of a gene, Igf2r, and a DNA methylation imprint. Also, it has
recently been shown that the imprinted endogenous mouse genes
Qgf2, Igf2r, H19, and Snrpn) and the human 15ql l -ql3
AS/PWS chromosomal region exhibit asynchronous timing of
replication between the paternal and maternal chromosomes, with
the paternal aHele always replicating early and the maternal alkie
always replicating late.37 This suggests that imprinted genes are
located within large domains having differential DNA replication
patterns, which could be altered by the chromosomal
rearrangements in these patients. We are currently investigating
whether the methylation changes observed in these unique AS
and PWS patients are associated with changes in replication
timing, DNase I hyperaensitivity, and transcription of the ZNF127
gene, in order to determine if these rearrangements can be
classified as functional position effects.
Unlike the other unique patients reported here, the AS157
siblings have no detectable deletion within 15ql 1 - q l 3 (see Table
1). Furthermore, there was biparental inheritance of proximal
and distal chromosome 15 markers which excludes paternal
disomy as an explanation for these children's AS phenotype and
AS methylation pattern at ZNF127 and D15S63. This does not
seem to be an isolated family, as more recent studies of another
AS sibship and a PWS sibship having biparental inheritance, show
that each affected individual has typical AS and PWS methylation
patterns, respectively, at D15S9 and D15S63 (A. Reis and B.
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Table 1. Clinical and mnlnailar data on AS and PWS brnOiet
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nonraw^wv
PW8
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O1S563
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ABdei are inHir«t>rf by «*"g1""e the highett mnifmiw weight allde the # 1, and the next highest allele the f 2, etc. (lee Materials and Method*), del
- deletion pat =• paternal, mat = maternal, ND - not done, F - father, P - proband, M - mother, AS - Angriman syndrome, PWS •= Prader-Wflli
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of 4.3, 4.0, and 3.5 kb bandi compared to nonnali.
and6), putting their DNA methylation out of the nonnal range
approaching a typical PWS pattern.
DNA methylation of unique AS and PWS patients at the
D15S63 locus
The patients discussed above were subsequently tested for
methylation status at the D15S63 locus (Fig. 1) using the
mkrodissection clone PW71, which also detects a parent-specific
methylation imprint." Figure 4 shows the results of the unique
AS patients. The ratio of the 6.0 Id) band divided by the 4.4 kb
band allows distinction among AS deletion/UPD (range
0.02-0.13; median 0.07, n = 21), normal controls (range
0.46-1.61; median 0.97, n = 14), and PWS deletion/UPD
patient samples (range 7.13-29.30; median 12.25, n = 14)
(Driscoll etal., in preparation). The AS013 siblings having the
small deletion demonstrate methylation ratios in the normal range
(Fig. 4;lane3 = 1.14, Iane4= 1.14, and lane 5 = 1.15). The
AS157 siblings in Fig. 4, lanes 8 (ratio = 0.09) and 9 (ratio =
0.17), by contrast, demonstrate a methylation pattern very close
to the AS deletion/UPD range, and similar to the AS UPD in
lane 7 (ratio = 0.13).
The D15S63 methylation pattern of the atypical PWS patients
having a ring 15 (PW108 and PW66), is like that of nonnal
controls (data not shown). Patient PW93 is deleted for DJ5S63,
and as expected, shows a methylation pattern similar to other
PWS deletion samples.19
These unique patients were also examined at other loci within
15qll— ql3 that do not detect a parent of origin methylation
difference. '• Loci D15S13, GABRB3, and P showed no altered
methylation pattern in these patients.
DISCUSSION
The genes causing the AS and PWS phenotypes are most likely
distinct loci.22- ^-^ Many researchers 16>24'26 postulate the AS
and PWS gene(s) can be localized by using unique patients to
define a 'smallest region of deletion overlap (SRO).' The AS
siblings deleted only for D15S10, D15S113, and GABRB3 loci
and the PWS patient PW93 are critical to this line of reasoning.
However, we have presented evidence that alterations on
chromosome 15 can affect the DNA methylation of loci several
megabases away in these and other patients. The mechanism(s)
of genomk imprinting is (are) unknown, but there is evidence
indicating DNA methylation may be involved.21-27-28 Therefore,
using these exceptional microdeletion patients to assign critical
regions for AS and PWS may be creating an oversimplified view.
It may be that genes both within and outside the AS and PWS
SROs, but within the 15ql 1 —ql3 region, can influence the
phenotypic outcome.
The modification of DNA methylation imprints at loci distant
from the chromosomal rearrangements in the AS and PWS
prtlirtils reported here suggests that mechanisms similar to position
effects in Drosophilal29-30 spreading of inactivation into
autosomes in mammalian X:autosome translocations,31-32 and
defective gene regulation resulting from translocations in various
human cancers,33"34-33 may also be involved in the imprinting
process of chromosome 15. In the rearrangements within
chromosome 15ql 1 —ql3 that we describe, the ZNF127geac and
die D15S63 locus were not directly involved (except for patient
PW93 which was deleted for D1SS63), but are now distantly
flanked by different DNA sequences which may have long range
cis-acting effects on these loci (refer to Fig. 1). Chromosome
15 alterations in these patients may cause a disruption of the local
chromatin conformation, which in turn may alter dc-novo or
maintenance DNA methylation of loci distant from the alteration
on the chromosome. Loci D15S13, GABRB3, and P within
15q l l -q l3 , which do not exhibit parent specific methylation
differences between AS and PWS patients, were not altered in
these patients. Thus, the methylation change only seems to occur
in loci which have a parent-specific methylation.
Interestingly, the AS013 sibship, even though they inherited
the same small deletion from their mother, showed a varied DNA
methylation pattern for ZNF127from leukocytes (Fig. 2a). The
reasons for this are not yet understood, but the difference in
methylation from normal is significant and reproducible, and it
is interesting that the male siblings have a different pattern from
die female sibling. We are aware of a classical PWS patient
(GO 168) who is deleted for loci D15S11 to D15S24, but leaves
ZNF127 intact and has a normal biparental methylation pattern
(B.Horsthemke, unpublished data). In contrast to the other
patients reported here, the deletion breakpoint is very close to
the ZNF127 locus and it may be that the chromatin structure is
affected in a different way compared to die other unique patients.
Since AS and PWS are neurobehavioral disorders, the crucial
tissue to examine in all of these patients would be the brain, which
at present is not feasible.
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Figure 3. Methylation status at the D15S9 locus (ZNF127geat) of PWS patients. Methods are as described in figure 2. A) Lane 1 is a normal control, lane 2 (overloaded)
is the atypical PWS patient PW66 who has a ring IS (rl5) chromosome, lane 3 is a PWS maternal UPD, lane 4 is PW93, lane 5 is a normal control, and lane
6 is the atypical PWS patient PW108 having a ring IS chromosome. B) Laser densitometry of the samples in A. Note the reduction of the 3.5 kb band in the PWS
samples compared to the normal controls.
Del
4.4-
10 11 12
Figure 4. Methylation status at the D15S63 locus in AS patients. TheAS013 affected siblings (lanes 3 -5 ) show a pattern essentially like that of the normal control
in lane 6, even though these lanes are overloaded. The AS1S7 affected siblings in lanes 8 and 9, however, show a methyiation pattern identical to that of the AS
paternal UPD in lane 7. Also shown is an AS patient with a deletion in lane 12.
Horstbemke, in preparation). Since the AS1S7 siblings have
alterations of the DNA methylation imprint at two loci seperated
by more that 1Mb, they most likely do not have a mutation in
an 'AS gene*. Therefore, it is tempting to speculate that they
may have a disruption in the lSql 1 - q l 3 imprinting process to
explain their phenotype. Valuable insights into the process of
genomic imprinting may come from further studies of unique
AS and PWS patients such as those described here.
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MATERIALS AND METHODS
Patients AS013P1, AS013P2, and AS013P3 have the classical clinfcal presentation
of Angehnan syndrome and have been described previously.22-23 AS137P1 and
AS1S7P2 also have die classical AS phenotype.3 PW93 and PW66 have been
previously described.12 PW93 has classical PWS and PW66 (ring IS
Cj OSS LUaUiy ICfltUTCS 01 PW>S, DUt IS DOt ClWffK*fll SffllllViY. t
patient with a ring 15 chromosome (PW108), has all die major characteristics
of PWS including the neonatal hypotoma and poor feeding, obesity and
hyperphagia, hypogonadixm, mental retardation and obsessive-compulsive
behavior, but "^  lacks tbe cbaractenstic ocxs and *w* hyperpbaoa, obesay, mental
retardation and hypogonadism are milder than described for rlstiirsl PWS.4
Molecular studies
DNA was isolated from peripheral blood leukocytes of patients, parents, and
normal controls by standard methods. DNA digestion, Southern transfer, and
probe hybridization were performed as previously described.2* The presence or
absence of deletions within 15qll-ql3 were determined by a mmhmtinn of
restriction tiagiura* length polymorphism studies,"-23 and quantitative estimates
of DNA dosage31 measured by laser denskometry (see below). A variable
number of tandem repeats probe from the 15q teJomere l3& was also used for
UPD analysis. Restriction enzymes used to detect polymorphisms were:
D7557WBglH, D75S5VScaI, £>75577/RsaI, D75S73/TaqL G47«fiJ/XbaI (for
AS013 fianfly only) and MspL Z)7tf 72/ScaL D75SW/AhiI. Dosing of lSql 1 -q l3
loci was done by 1—***'*^ isitiwiiriry comparison wkhin each lane to a chromosome
13 probe H2-26. Tbe cDNA DN34 was isolated from a human fetal brain
Ubrary," and the probe PW71 (D75SH) is a microdissectian done which maps
to 15qll-ql3.'9.«
DNA methyunion was analyzed by <tig«ring 10 fig of leukocyte DNA first
with EcoRI (DN34)>* or Hindm (PW71)1' and then with the methyl-sensitive
enzyme Hpall. Hpall recognizes the sequence 5'-CCGG-3', and will not cut if
ttw lotcrnu cytosmc is i
Densltouietry was performed on a Pharmacia LKB UltroSctn XL. Peak height
and area under the curve indicate band intensity on autoradiograms. Tbe ratios
given for ZNF127 were derived by dividing the combined relative area under
the 4.0 and 4.3 kb peaks by die relative area under tbe 3.5 fcb peak. Those for
D15S63 were derived by dividing the 6.0 kb peak by the 4.4 kb peak.
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ABBREVIATIONS
AS = Angdman syndrome, PWS - Prader-Wiffi syndrome, SRO - smallest
region of deletion overlap, F ™ fitfher, P ™ proband, M H IIH<IICJ, del • deletion,
mat — •"—»""'. pat — paternal ND =• not done, Nl — normal.
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